Strohbehn, Garth W.
Goldstein, Daniel A.
Article History
First Online: 8 April 2021
Competing interests
: D.A.G. has received institutional research funding from Bristol–Myers Squibb, Jannsen and Merck, has received consultancy fees from VIVIO Health and owns shares in VIVIO Health and TailorMed. G.W.S. is employed by the United States government; the views expressed are those of the authors alone and do not necessarily represent those of the Department of Veterans Affairs or the US Government.